Search

everythinglearnresearchcommunity

for

Search:↓

Cellular and immunotherapies show promise for healing chronic wounds but need more research.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Different parts of the body have unique immune characteristics in their skin.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Regulatory T cells are essential for normal and improved wound healing in mice.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Using healthy donor stem cells can potentially calm overactive immune cells and reduce inflammation in severe hair loss patients, offering a possible treatment method.

Treg cell-based therapies might help treat hair loss from alopecia areata, but more research is needed to confirm safety and effectiveness.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Mast cells and CD8 T cells interact closely in skin diseases, affecting each other's behavior and contributing to conditions like psoriasis and eczema.

Changes to the Foxp3 protein affect how well regulatory T cells can control the immune system, which could help treat immune diseases and cancer.

A specific DNA sequence caused hair loss in male mice by activating immune cells and increasing a certain immune signal.

Tenofovir is more effective than adefovir for resistant hepatitis B, Fibroscan is good for assessing liver damage, regulatory T cells may help hepatitis C persist, and other insights into liver health and disease were found.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Lower CD200R1 on certain immune cells is linked to more severe rheumatoid arthritis and immune imbalance.

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

Immune cells are essential for skin regeneration using biomaterial scaffolds.

FoxN1 overexpression in young mice harms immune cell and skin development.

Understanding the immune-related causes of Alopecia Areata has led to potential treatments like JAK inhibitors.